- /
- Supported exchanges
- / US
- / YDES.NASDAQ
YD Bio Ltd (YDES NASDAQ) stock market data APIs
YD Bio Ltd Financial Data Overview
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get YD Bio Ltd data using free add-ons & libraries
Get YD Bio Ltd Fundamental Data
YD Bio Ltd Fundamental data includes:
- Net Revenue: 1 239 K
- EBITDA: -6 341 945
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
YD Bio Ltd News
New
YD Bio Limited reports 1H results
* YD Bio Limited press release [https://seekingalpha.com/pr/20635333-yd-bio-limited-reports-unaudited-financial-results-for-the-six-months-ended-june-30-2026] (YDES [https://seekingalpha.com/symbol/...
Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update
(RTTNews) - Today's top gainers include Innovative Eyewear, which announced preliminary second-quarter net sales; Seer, following an acquisition proposal; and Orthofix and Enovis, which stand to benef...
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection techno...
YD Bio Outlines An Ambitious 2026 Roadmap Following A Transformative 2025
(RTTNews) - YD Bio Limited (YDES) announced that it is entering 2026 with momentum, after completing a series of major scientific and regulatory milestones that the company believes will accelerate it...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.